Credit Agricole S A Clovis Oncology, Inc. Transaction History

Credit Agricole S A

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2017 Feb 13, 2018	SELL	$57.69 - $84.58 $1.12 Million - $1.65 Million	-19,500 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$67.17 - $84.81 $1.28 Million - $1.61 Million	19,000 Added 3800.0%	19,500 $1.61 Million
Q2 2017 Aug 14, 2017	BUY	N/A	500	500 $47,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Credit Agricole S A, based on Form 13F filings with the SEC.

Stay updated on Credit Agricole S A with notifications on news.